Analysis: U.S. Health Care Cost Drivers Focus on Providers Rather Than Insurers
A commentary argues that healthcare providers, not insurers, are primarily responsible for excess U.S. health care costs, noting that insurers operate on very low profit margins. The piece contends that private insurers extract only $10-15 per $100 of healthcare premiums while providers account for most of the cost difference between the U.S. and other developed nations. The analysis suggests progressives' focus on insurers as villains may be misdirected and counterproductive to achieving actual cost reduction.
The article presents an economic argument that U.S. health care's high costs stem mainly from provider pricing and practices rather than insurer profiteering. The author notes that health insurers consistently operate with profit margins near zero, meaning the portion of premiums going to insurers covers operating costs rather than shareholder returns. The piece argues that while private insurers may be inefficient middlemen, they are not the primary driver of American health care costs exceeding those in other developed nations. The author hypothesizes that insurers have become "sin-eaters" for the healthcare system—scapegoats bearing public anger because they are the visible gatekeepers who deny coverage, while providers remain less scrutinized despite capturing most excess costs. The commentary concludes that progressive focus on attacking insurers may be emotionally satisfying but strategically counterproductive to achieving meaningful cost reduction.
What's missing
The article does not provide specific data on what proportion of excess U.S. healthcare costs (relative to other developed nations) is attributable to providers versus insurers, nor does it cite peer-reviewed economic analyses quantifying this breakdown. The claim about $10-15 per $100 going to insurers lacks a source citation. Additionally, the piece does not address potential mechanisms by which insurers might influence provider costs through negotiating power or payment structures.
What different sources said
- Hacker NewsCenter
Providers, not insurers, are responsible for excess U.S. health care cost (2024)
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.